Human carcinogenesis and alcohol in hepato-gastroenterology

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 4, 2012, Pages 512-518

  Testino, G ^a   Borro, P ^a   Ancarani, O ^a   Sumberaz, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Alcohol; Cancer; Carcinogenesis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETALDEHYDE; ALCOHOL; ALDEHYDE DEHYDROGENASE; CYTOCHROME P450; MYELOPEROXIDASE; RETINOID;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOLIC BEVERAGE; ANGIOGENESIS; BREAST CANCER; CANCER CONTROL; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; COMET ASSAY; DIGESTIVE SYSTEM CANCER; DNA FRAGMENTATION; DNA METHYLATION; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; ENZYME POLYMORPHISM; ESOPHAGUS CANCER; GENE EXPRESSION; GENOTOXICITY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSURVEILLANCE; LARYNX CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOUTH CANCER; MUTAGENESIS; NONHUMAN; NUTRITIONAL DEFICIENCY; ONCOGENE; PANCREAS CANCER; PHARYNX CANCER; REVIEW; SEROTONINERGIC SYSTEM; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; ANIMAL; BEVERAGE; CELL TRANSFORMATION; DIGESTIVE SYSTEM TUMOR; DOSE RESPONSE; DRINKING BEHAVIOR; FEMALE; HEALTH CARE POLICY; MALE; METABOLISM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE;

ALCOHOL DRINKING; ANIMALS; BEVERAGES; CELL TRANSFORMATION, NEOPLASTIC; DIGESTIVE SYSTEM NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; HUMANS; MALE; NUTRITION POLICY; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEX FACTORS;

EID: 84862662704     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. BOFFETTA P, HASHIBE M. Alcohol and cancer. Lancet Oncol 2006; 7: 149-156.
2. REHM J, BALIUNAS D, BORGES GLG. The relation between different dimensions of alcohol consumption and burden disease: An overview. Addiction 2010; 105: 817-843.
3. SPECIAL REPORT: POLICY. A review of human carcinogens-Part E: Tobacco, area nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033-1034.
4. CORRAO G, BAGNARDI V, ZAMBON A, LA VECCHIA C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613-619.
5. WORLD CANCER RESEARCH FUND. Food, nutrition, physical activity, and prevention of cancer: A global perspective. Washington (DC): AIRC, 2010.
6. THYGESEN LC, MIKKELSEN P, ANDERSEN TV. Cancer incidence among patients with alcohol use disorders -Long-term follow-up. Alcohol Alcohol 2009; 44: 387-391.
7. BOFFETTA P, HASHIBE M, LA VECCHIA C. The burden of cancer attributable to alcohol drinking. Int J Cancer 2006; 119: 884-887.
8. LACHENMEIER DW, SOHNIUS EM. The role of acetaldehyde outside ethanol metabolism in the carcinogenicity of alcoholic beverages: Evidence from a large chemical survey. Food Chem Toxicol 2008; 46: 2903-2911.
9. SEITZ HK, STICKEL F, HOMANN N. Pathogenetic mechanisms of upper aerodigestive tract cancer in the alcoholic. Int J Cancer 2004; 108: 483-487.
10. SEITZ HK, STICKEL F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599-612.
11. GYAMFI MA, WAN YJY. Pathogenesis of alcoholic liver disease: The role of nuclear receptors. Exp Biol Med 2010; 235: 547-560.
12. POSCHL G, SEITZ HK. Alcohol and cancer. Alcohol Alcohol 2004; 39: 155-165.
13. DRUESNE-PECOLLO N, TEHARD B, MALLET Y, GERBER M, NORAT T, HERCBERG S, LATINO-MARTEL P. Alcohol and genetic polymorphisms: Effect on risk of alcoholrelated cancer. Lancet Oncol 2009; 10: 173-180.
14. JELSKI W, SZMITKOWSKI M. Alcohol dehydrogenase and aldehyde dehydrogenase in the cancer diseases. Clin Chim Acta 2008; 395: 1-5.
15. SALASPURO M. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scand J Gastroenterol 2009; 44: 912-925.
16. NAHON P, SUTTON A, RUFAT P. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 2009; 50: 1-10.
17. SEITZ HK, BECKER P. Alcohol metabolism and cancer risk. Alcohol Res Health 2007; 30: 38-41.
18. GROSSI S, SUMBERAZ A, GOSMAR M, MATTIOLI F, TESTINO G, MARTELLI A. DNA damage in peripheral blood lymphocytes of patients with cirrhosis to alcohol abuse or to hepatitis B and C viruses. Eur J Gastroenterol Hepatol 2008; 20: 22-25.
19. MORGAN TR, MANDAYAM S, JAMAL M. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127: S87-S96.
20. SHERON N, OLSEN N, GILMORE I. An evidence-based alcohol policy. Gut 2008; 57: 1341-1344.
21. ALTIERI A, BOSETTI C, GALLUS S. Wine, beer and spirits and risk of oral and pharyngeal cancer: A case-control study from Italy and Switzerland. Oral Oncol 2004; 40: 904-909.
22. OGDEN GR. Alcohol and oral cancer. Alcohol 2005; 35: 169-173.
23. SEITZ HK, MEIER P. The role of acetaldehyde in upper digestive tract cancer in alcoholics. Transl Res 2007; 149: 293-297.
24. FRANKE A, TEYSSEN S, SINGER MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis 2005; 23: 204-213.
25. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Monographs on the evaluation of carcinogenic risks in humans. Alcohol consumption and ethyl carbamate, Vol. 96, Lyon, France, 2010.
26. TALAMINI R, POLESEL J, GALLUS S. Tobacco smoking, alcohol consumption and pancreatic cancer risk: A case-control study in Italy. Eur J Cancer 2009; 46: 370-376.
27. STICKEL F, SCHUPPAN D, HAHN EG, SEITZ HK. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 2002; 51: 132-139.
28. YAMAUCHI M, NAKAHARA M, MAEZAWA Y. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Am J Gastroenterol 1993; 88: 39-43.
29. CORRAO G, CARLE F, LEPORE AR. Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: A case-control study. Eur J Epidemiol 1992; 8: 634-639.
30. MACHIDA K. TLRs, alcohol, HCV, and tumorigenesis. Gastroenterol Res Pract 2010; 2010: 1-8.
31. HASSAN MM, HWANG LY, HATTEN CJ. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-1213.
32. TESTINO G, ICARDI G. Hepatocellular carcinoma and interferon therapy in HCV compensated cirrhosis: Evaluation in relation to virological response. Hepatogastroenterology 2005; 52: 1-2.
33. TESTINO G. Alcoholic diseases in hepato-gastroenterology: A point of view. Hepatogastroenterology 2008; 55: 371-377.
34. JELSKI W, SZMITKOWSKI M. Alcohol dehydrogenase and aldehyde dehydrogenase in the cancer diseases. Clin Chim Acta 2008; 395: 1-5.
35. ROSKAM T, YANG SQ, KOTEISH A. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am J Pathol 2003; 163: 1301-1311.
36. CICHOZ-LACH H, PARTYCKA J, NESINA I. Genetic polymorphism of alcohol dehydrogenase 3 in digestive tract alcohol damage. Hepatogastroenterology 2007; 54: 1222-1227.
37. LA VECCHIA C. Alcohol and liver cancer. Eur J Cancer Prev 2007; 16: 495-497.
38. BAGNARDI V, BLANGIARDO M, LA VECCHIA C, CORRAO G. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613-619.
39. BOYLE P, AUTIER P, BARTELINK H. European code against cancer and scientific justification: Third version (2003). Ann Oncology 2003; 14: 973-1005.